Paul Jenkins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Paul Jenkins has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Jim Zhong
Leeds Institute of Medical Research, University of Leeds, Leeds, UK
8 shared publications J. Zhong
Department of Interventional Radiology, Leeds General Infirmary, Leeds, UK
4 shared publicationsN. Gafoor
University Hospitals Plymouth NHS Trust, Derriford Road, Crownhill, Plymouth, Devon, PL6 8DH, UK
4 shared publicationsA. MacCormick
Peninsula Radiology Academy, Plymouth PL6 5WR, UK
3 shared publications- Andrew MacCormick
University Hospitals Plymouth NHS Trust, Plymouth, UK
3 shared publications C. Roobottom
University Hospital Plymouth NHS Trust, Plymouth, UK
3 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0337255
Determining essential priorities for future investigation - A national consensus exercise in Interventional Oncology (DEFINE-IO) – An a priori protocol
Introduction: Interventional Oncology (IO) is a rapidly developing subspecialty within interventional radiology (IR), offering minimally invasive, precise and targeted cancer therapies. Despite its transformative potential, IO faces challenges in identifying critical research priorities amidst limited funding and resources. The DEFINE-IO study aims to identify the most pressing research priorities in IO to guide researchers, policy makers, and funding bodies in driving innovation and improving cancer outcomes. Methods and analysis: This study comprises two phases: a modified e-Delphi process and a multi-criteria decision analysis (MCDA). The e-Delphi process will involve three rounds, with round 1 dedicated to generating research topics, followed by rounds 2 and 3, which will focus on refining and achieving consensus on the identified topics. The final consensus will yield a list of 25 research priorities, which will be evaluated during an in-person MCDA session. These priorities will be assessed against three predefined criteria: urgency, feasibility/equipoise, and affordability, to establish a strategic roadmap for research in IO. Ethics and dissemination: Formal ethics approval was deemed not necessary. Findings of the study will be presented at major conferences and published in a peer-reviewed journal. The findings will also be shared with funding bodies and policymakers to help guide future research directions.
- 18 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0337255
Open AccessDetermining essential priorities for future investigation - A national consensus exercise in Interventional Oncology (DEFINE-IO) – An a priori protocol
Introduction: Interventional Oncology (IO) is a rapidly developing subspecialty within interventional radiology (IR), offering minimally invasive, precise and targeted cancer therapies. Despite its transformative potential, IO faces challenges in identifying critical research priorities amidst limited funding and resources. The DEFINE-IO study aims to identify the most pressing research priorities in IO to guide researchers, policy makers, and funding bodies in driving innovation and improving cancer outcomes. Methods and analysis: This study comprises two phases: a modified e-Delphi process and a multi-criteria decision analysis (MCDA). The e-Delphi process will involve three rounds, with round 1 dedicated to generating research topics, followed by rounds 2 and 3, which will focus on refining and achieving consensus on the identified topics. The final consensus will yield a list of 25 research priorities, which will be evaluated during an in-person MCDA session. These priorities will be assessed against three predefined criteria: urgency, feasibility/equipoise, and affordability, to establish a strategic roadmap for research in IO. Ethics and dissemination: Formal ethics approval was deemed not necessary. Findings of the study will be presented at major conferences and published in a peer-reviewed journal. The findings will also be shared with funding bodies and policymakers to help guide future research directions.
- 18 June 2026
- Published by Elsevier in Clinical Radiology
- Vol. 100, 107406
An Overview of Interventional Pulmonary Embolism Management in the United Kingdom in 2026
- 18 June 2026
- Published by Elsevier in Clinical Radiology
- Vol. 100, 107406
An Overview of Interventional Pulmonary Embolism Management in the United Kingdom in 2026
- Open Access
- 26 May 2026
- Published by Springer Nature
Identifying needs and setting priorities in research for vascular interventional radiology
- 26 May 2026
- Published by Springer Nature
Open AccessIdentifying needs and setting priorities in research for vascular interventional radiology
- 17 March 2026
- Published by SAGE Publications in Trauma
- Vol. 28 (2-3) , 94-102
Traumatic splenic injury in the elderly population: Does management choice affect outcome?
Purpose: Trauma within older people is increasingly recognised as a different entity, with different management and outcomes to younger people. We aim to compare the 30-day survival and length of stay of splenic injury patients in English major trauma centres in an elderly trauma (65+) cohort in comparison to under 65. Methods: Data were obtained from the Trauma Audit Research Network of all Grade 2–5 American Association of Surgery in Trauma (AAST) splenic injuries admitted to English Major Trauma Centres between 01/01/17 and 31/12/21. End-points of mortality and length of stay were compared between the under 65 and 65+ groups according to treatment using descriptive statistics and multi-variable regression analysis. Results: In total, 802/3958 (20.2%) of admissions were 65+ and 2926/3958 (73.9%) were male. The proportion of AAST grades 3–5 was 41.3% (331/802) for 65+ and 52.3% (1652/3156) for under 65. A total of 12.8% (103/802) received embolisation in the 65+ group and 13.1% (413/3156) within the under 65 group. In total, 6.9% (55/802) in the 65+ group received splenectomy compared to 10.1% (319/3156). Within the 65+ group, 30-day mortality in the splenectomy group was 14.5% (8/55) compared to embolisation (18/103, 17.5%) and conservative (141/644, 21.9%). The 30-day mortality was (10.3%, 33/319) in those having a splenectomy as first treatment in the under 65's, compared with embolisation (26/413, 6.3%) and conservative management (197/2424, 8.1%). Embolisation failure was 3.9% (4/103) in the 65+ group and 7.3% (30/413) in the under 65 group. Splenectomy is associated with an increased length of stay at 1.20 (confidence interval (CI) 1.06, 1.37) times longer; however, this was not affected by age group. Conclusion: Mortality was higher in the over 65 cohort regardless of treatment. Splenectomy is associated with an increased length of stay compared to embolisation, however there is no clear interaction demonstrated between age and first treatment.
- 17 March 2026
- Published by SAGE Publications in Trauma
- Vol. 28 (2-3) , 94-102
Traumatic splenic injury in the elderly population: Does management choice affect outcome?
Purpose: Trauma within older people is increasingly recognised as a different entity, with different management and outcomes to younger people. We aim to compare the 30-day survival and length of stay of splenic injury patients in English major trauma centres in an elderly trauma (65+) cohort in comparison to under 65. Methods: Data were obtained from the Trauma Audit Research Network of all Grade 2–5 American Association of Surgery in Trauma (AAST) splenic injuries admitted to English Major Trauma Centres between 01/01/17 and 31/12/21. End-points of mortality and length of stay were compared between the under 65 and 65+ groups according to treatment using descriptive statistics and multi-variable regression analysis. Results: In total, 802/3958 (20.2%) of admissions were 65+ and 2926/3958 (73.9%) were male. The proportion of AAST grades 3–5 was 41.3% (331/802) for 65+ and 52.3% (1652/3156) for under 65. A total of 12.8% (103/802) received embolisation in the 65+ group and 13.1% (413/3156) within the under 65 group. In total, 6.9% (55/802) in the 65+ group received splenectomy compared to 10.1% (319/3156). Within the 65+ group, 30-day mortality in the splenectomy group was 14.5% (8/55) compared to embolisation (18/103, 17.5%) and conservative (141/644, 21.9%). The 30-day mortality was (10.3%, 33/319) in those having a splenectomy as first treatment in the under 65's, compared with embolisation (26/413, 6.3%) and conservative management (197/2424, 8.1%). Embolisation failure was 3.9% (4/103) in the 65+ group and 7.3% (30/413) in the under 65 group. Splenectomy is associated with an increased length of stay at 1.20 (confidence interval (CI) 1.06, 1.37) times longer; however, this was not affected by age group. Conclusion: Mortality was higher in the over 65 cohort regardless of treatment. Splenectomy is associated with an increased length of stay compared to embolisation, however there is no clear interaction demonstrated between age and first treatment.
- 10 February 2026
- Published by Elsevier in Clinical Oncology
- Vol. 52, 104077
Interventional Oncology Geographic Inequality—A Problem for Today
- 10 February 2026
- Published by Elsevier in Clinical Oncology
- Vol. 52, 104077
Interventional Oncology Geographic Inequality—A Problem for Today
- 16 January 2026
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 49 (7) , 1402-1410
Time to Splenic Embolisation in Trauma Patients Arriving at a Major Trauma Centre In-Hours or Out-of-Hours: A UK Multicentre Study
Purpose To determine whether time of arrival at a major trauma centre (MTC) influences embolisation rate, time to embolisation, embolisation failure and 30-day survival in adult trauma patients. Materials and Methods Data for adults (> 18 years) admitted to an MTC and recorded in the UK Trauma Audit and Research Network database between 01/01/17 and 31/12/21 were analysed. ‘In-hours’ was defined as Monday to Friday (excluding holidays) 09:00–17:00; all other times were ‘out-of-hours’. Descriptive and regression analyses assessed factors associated with time to embolisation and 30-day survival, and the relationship between these outcomes. Results Among 2,560 patients with splenic injury (Abbreviated Injury Scale (AIS) > 2) directly admitted to an MTC, 184 (7.2%) underwent embolisation within 24 h. Of these, 79% were male (145/184) with a median age of 42 years (IQR 27–56). Embolisation within 24 h occurred in 48/600 (8.0%) of patients admitted in-hours versus 136/1,960 (6.9%) out-of-hours. Embolisation failure rate was similar between the groups (6.3% (3/48) in-hours versus 9.6% (13/136) out-of-hours). American Association for the Surgery of Trauma (AAST) grade and probability of survival were similar across groups. Median time to embolisation was 159 min (95% CI 142–213) in-hours and 238 min (95% CI 210–288) out-of-hours. After adjustment, out-of-hours patients had 1.34 times longer time to embolisation (95% CI 1.02–1.76). Regression analysis showed no strong association between time of admission and 30-day survival (odds ratio [OR] 2.13; 95% CI 0.76–5.81). Time to embolisation also showed no relationship with survival (OR 1.00; 95% CI 1.00–1.00). Conclusion Although out-of-hours presentation delayed embolisation, this did not affect 30-day survival, suggesting current trauma workflows maintain clinical effectiveness despite temporal disparities in interventional radiology (IR) access. Graphical Abstract
- 16 January 2026
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 49 (7) , 1402-1410
Time to Splenic Embolisation in Trauma Patients Arriving at a Major Trauma Centre In-Hours or Out-of-Hours: A UK Multicentre Study
Purpose To determine whether time of arrival at a major trauma centre (MTC) influences embolisation rate, time to embolisation, embolisation failure and 30-day survival in adult trauma patients. Materials and Methods Data for adults (> 18 years) admitted to an MTC and recorded in the UK Trauma Audit and Research Network database between 01/01/17 and 31/12/21 were analysed. ‘In-hours’ was defined as Monday to Friday (excluding holidays) 09:00–17:00; all other times were ‘out-of-hours’. Descriptive and regression analyses assessed factors associated with time to embolisation and 30-day survival, and the relationship between these outcomes. Results Among 2,560 patients with splenic injury (Abbreviated Injury Scale (AIS) > 2) directly admitted to an MTC, 184 (7.2%) underwent embolisation within 24 h. Of these, 79% were male (145/184) with a median age of 42 years (IQR 27–56). Embolisation within 24 h occurred in 48/600 (8.0%) of patients admitted in-hours versus 136/1,960 (6.9%) out-of-hours. Embolisation failure rate was similar between the groups (6.3% (3/48) in-hours versus 9.6% (13/136) out-of-hours). American Association for the Surgery of Trauma (AAST) grade and probability of survival were similar across groups. Median time to embolisation was 159 min (95% CI 142–213) in-hours and 238 min (95% CI 210–288) out-of-hours. After adjustment, out-of-hours patients had 1.34 times longer time to embolisation (95% CI 1.02–1.76). Regression analysis showed no strong association between time of admission and 30-day survival (odds ratio [OR] 2.13; 95% CI 0.76–5.81). Time to embolisation also showed no relationship with survival (OR 1.00; 95% CI 1.00–1.00). Conclusion Although out-of-hours presentation delayed embolisation, this did not affect 30-day survival, suggesting current trauma workflows maintain clinical effectiveness despite temporal disparities in interventional radiology (IR) access. Graphical Abstract
- Open Access
- 21 November 2025
- Published by Elsevier in Clinical Radiology
- Vol. 94, 107185
IO1-UK: a cross-sectional study to re-evaluate the provision of interventional oncology services across the United Kingdom
- 21 November 2025
- Published by Elsevier in Clinical Radiology
- Vol. 94, 107185
Open AccessIO1-UK: a cross-sectional study to re-evaluate the provision of interventional oncology services across the United Kingdom
- Open Access
Determining Essential priorities for Future Investigation - a National consensus Exercise in Interventional Oncology (DEFINE-IO) – A priori protocol
Introduction: Interventional Oncology (IO), is a rapidly developing subspecialty within interventional radiology (IR), offering minimally invasive, precise and targeted cancer therapies. Despite its transformative potential, IO faces challenges in identifying critical research priorities amidst limited funding and resources. The DEFINE-IO study aims to identify the most pressing research priorities in IO to guide researchers, policy makers, and funding bodies in driving innovation and improving cancer outcomes. Methods and analysis: This study comprises two phases: a modified e-Delphi process and a multi-criteria decision analysis (MCDA). The e-Delphi process will involve three rounds, with round 1 dedicated to generating research topics, followed by rounds 2 and 3, which will focus on refining and achieving consensus on the identified topics. The final consensus will yield a list of 25 research priorities, which will be evaluated during an in-person MCDA session. These priorities will be assessed against three predefined criteria: urgency, feasibility/equipoise, and affordability, to establish a strategic roadmap for research in IO. Ethics and dissemination: Formal ethics approval was deemed not necessary. Findings of the study will be presented at major conferences and published in a peer-reviewed journal. The findings will also be shared with funding bodies and policymakers to help guide future research directions. Abstract Figure:
Open AccessDetermining Essential priorities for Future Investigation - a National consensus Exercise in Interventional Oncology (DEFINE-IO) – A priori protocol
Introduction: Interventional Oncology (IO), is a rapidly developing subspecialty within interventional radiology (IR), offering minimally invasive, precise and targeted cancer therapies. Despite its transformative potential, IO faces challenges in identifying critical research priorities amidst limited funding and resources. The DEFINE-IO study aims to identify the most pressing research priorities in IO to guide researchers, policy makers, and funding bodies in driving innovation and improving cancer outcomes. Methods and analysis: This study comprises two phases: a modified e-Delphi process and a multi-criteria decision analysis (MCDA). The e-Delphi process will involve three rounds, with round 1 dedicated to generating research topics, followed by rounds 2 and 3, which will focus on refining and achieving consensus on the identified topics. The final consensus will yield a list of 25 research priorities, which will be evaluated during an in-person MCDA session. These priorities will be assessed against three predefined criteria: urgency, feasibility/equipoise, and affordability, to establish a strategic roadmap for research in IO. Ethics and dissemination: Formal ethics approval was deemed not necessary. Findings of the study will be presented at major conferences and published in a peer-reviewed journal. The findings will also be shared with funding bodies and policymakers to help guide future research directions. Abstract Figure:
- 19 June 2025
- Published by Elsevier in Clinical Radiology
- Vol. 88, 106994
Pictorial review of the use of percutaneous mechanical thromboaspiration in peripheral vascular occlusions
- 19 June 2025
- Published by Elsevier in Clinical Radiology
- Vol. 88, 106994
Pictorial review of the use of percutaneous mechanical thromboaspiration in peripheral vascular occlusions
- 27 March 2025
- Published by Elsevier in Clinical Radiology
- Vol. 85, 106904
Variation in paediatric splenic trauma management in adult and combined major trauma centres in England
- 27 March 2025
- Published by Elsevier in Clinical Radiology
- Vol. 85, 106904
Variation in paediatric splenic trauma management in adult and combined major trauma centres in England